Goldman Sachs
KMTS

Goldman Sachs’s Kestra Medical Technologies KMTS Stock Holding History

Goldman Sachs’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.75M Buy
288,354
+15,902
+6% +$375K ﹤0.01% 3568
2025
Q4 		$7.23M Buy
272,452
+200,130
+277% +$5.15M ﹤0.01% 3399
2025
Q3 		$1.72M Buy
72,322
+56,492
+357% +$1.01M ﹤0.01% 4602
2025
Q2 		$262K Buy
+15,830
New +$346K ﹤0.01% 5518

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs's KMTS Position: Q1 2026 in Review

Goldman Sachs increased its Kestra Medical Technologies (KMTS) stake by 5.8% in Q1 2026, buying an estimated $375K and bringing the position to 288,354 shares worth $5.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3568.

Goldman Sachs first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $7.23M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Goldman Sachs held 288,354 shares of Kestra Medical Technologies worth $5.75M as of Q1 2026.
  • Goldman Sachs bought 15,902 Kestra Medical Technologies shares in Q1 2026, an estimated $375K.
  • Kestra Medical Technologies made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3568 holding.
  • Goldman Sachs first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • Goldman Sachs's Kestra Medical Technologies position peaked at $7.23M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.